Status:
COMPLETED
Elimination of Albumin-Bound Substances by MARS and Prometheus
Lead Sponsor:
Medical University of Graz
Collaborating Sponsors:
Fresenius Medical Care North America
Conditions:
Liver Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This trial compares the efficacy of two artificial liver support systems, MARS (Molecular Adsorbents Recirculating System) and Prometheus (FPSA, Fractionated Plasma Separation and Adsorption), in remo...
Eligibility Criteria
Inclusion
- consecutive patients with acute-on-chronic liver failure (severe deterioration of chronic liver disease) unresponsive to standard medical treatment for \>=48 hours
Exclusion
- arterial hypotension
- extrahepatic malignancy
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
End Date :
April 1 2004
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00407004
Start Date
March 1 2003
End Date
April 1 2004
Last Update
December 4 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Graz
Graz, Austria, A-8036